Keywords: MR-Guided Focused Ultrasound, MR-Guided Interventions
Motivation: The symptoms of dysmenorrhea, infertility and hypermenorrhea caused by adenomyosis seriously affect the daily life of patients. Therefore, there is an urgent need for an effective non-invasive treatment of uterine adenomyosis.
Goal(s): To investigate the safety and efficacy of Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgFUS) treatment on adenomyosis.
Approach: MRgFUS was performed on 62 adenomyosis patients to observe the adverse reactions during treatment, the changes of uterine size and improvement of dysmenorrhea.
Results: All 62 patients successfully underwent MRgFUS treatment without severe adverse reactions(average ablation rate 69.12%±17.64%). Post-treatment uterine volume and dysmenorrhea scores showed statistically significant improvements compared to pre-treatment (p<0.05).
Impact: MRgFUS is safe and effective in the treatment of uterine adenomyosis, and is a new non-invasive treatment approach.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords